Latest Daniel Von Hoff Stories
Encouraging Reduction In Thromboembolic Events Following Protocol Amendment SAN DIEGO, May 31, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
Baylor Research Institute, TGen extend collaboration to give patients greater access to liquid biopsies, gene sequencing, personalized vaccines and one-of-a-kind clinical trials DALLAS,
Data to support ongoing work with Halozyme's investigational new drug PEGPH20 in combination with immuno-oncology agents SAN DIEGO, April 20, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 2, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced the creation of
TIANJIN, China, Feb.
Study to test drug designed to help patient in late stages of disease GILBERT, Ariz., Jan.
MANHATTAN BEACH, Calif., Jan.
Mattress Firm Stores Across U.S. Raising Funds for One of Most Deadly, Yet Under-Funded Diseases HOUSTON, Nov.
Urges provinces to move quickly to fund first new treatment for pancreatic cancer approved in Canada in 20 years HALIFAX, Sept.
Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in Scottsdale, would like to jointly announce CRAB’s assumption of responsibility for the PCRT,
- The parings of haberdine; also, any kind of fragments.